NCT06685523 is a NA clinical trial of Subgingival debridement in Peri-implantitis, sponsored by Kubilay BARIŞ.

Who is sponsoring NCT06685523?

NCT06685523 is sponsored by Kubilay BARIŞ.

What drugs are being tested in NCT06685523?

Interventions in NCT06685523: Subgingival debridement, Er:YAG laser decontamination, Diyot laser decontamination.

What condition does NCT06685523 study?

NCT06685523 studies Peri-implantitis.

Is NCT06685523 still recruiting?

NCT06685523 is currently recruiting now. Last updated 12 November 2024.

Last reviewed 2024-11-12 · How we verify

NCT06685523

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Fractalkine and Its Receptor in Peri-implantitis

Recruiting now NA Last updated 12 November 2024

What this trial tests

NA trial testing Subgingival debridement in Peri-implantitis in 100 participants. Currently enrolling.

Timeline

8 November 2024

Primary endpoint
8 May 2025

15 May 2025

Quick facts

Lead sponsor	Kubilay BARIŞ
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	100
Start date	8 November 2024
Primary completion	8 May 2025
Estimated completion	15 May 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Subgingival debridement
Er:YAG laser decontamination
Diyot laser decontamination

Conditions studied

Peri-implantitis — all drugs for Peri-implantitis →

Sponsor

Kubilay BARIŞ

Who can join

Adults 40 to 60, any sex, with Peri-implantitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, mechanical debridement group, Er:YAG laser group and diode laser group will be compared in terms of reducing peri-implant sulcus depth in the treatment of peri-implantitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peri-implantitis

Currently open trials in the same condition.

NCT07471386 — Adjunctive Keratinized Mucosa Augmentation in Peri-Implantitis · NA · recruiting
NCT07088679 — Natural Bioactive Gel for Peri-Implantitis · NA · recruiting
NCT06830200 — Peri-implantitis Treatment With Chitosan Brush · NA · recruiting
NCT06957652 — Reconstructive Treatment of Peri-implantitis With Combined Defects · NA · recruiting
NCT06262035 — Transcriptome, Proteome and Microbiome Profile in Periodontal and Peri-implant Diseases · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06685523 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kubilay BARIŞ
Last refreshed: 12 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06685523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing